Introduction
Healthcare practitioners’ primary aim is to maintain people’s health. However, in addition to this vital role, providers must also uphold the ethical standards of their profession. Genetic testing, especially prenatal, is accompanied by many fears, which makes some couples resistant or hesitant as to whether to resort to it. The preset paper provides a rationale for genetic screening, analyzes ethical concerns, and offers intervention suggestions for the couple in question.
The Rationale behind Genetic Testing and Screening
Genetic testing is one of the most reliable ways to guide parents’ reproductive decisions and optimize healthcare outcomes. Prenatal screening helps to identify whether a couple is at an increased risk of having a baby with a genetic condition. Given the family history of both parents, taking tests could optimize their healthcare resources. For instance, knowing the baby has cystic fibrosis can help parents and providers make better health-related choices for the baby once it is born (Farrell et al., 2020).
On the same note, identifying sickle cell anemia will enable the provider to develop a plan for the family to reduce the child’s exposure to the disease. With the latest testing methods, which eliminate risks to the fetus, the process is almost painless and results are accurate (Erlich et al., 2022). Furthermore, with genetic testing results, the couple will have an opportunity to prepare emotionally for the birth of a child with a genetic condition, or will be relieved and feel no pressure if the tests are negative.
Ethical Concerns
While prenatal tests can produce valuable data regarding the future baby’s health, many couples are doubtful whether they want to undergo the procedure. Ethical aspects, such as confidentiality, privacy, informed choice, and risks versus benefits, are relevant (Kessels et al., 2020). Privacy and confidentiality are among the main fears, as the couple may be worried about stigmatization or discrimination based on genetic tests.
Informed consent can be an issue as future parents may be suspicious about the risks and limitations of testing. Also, they may have apprehensions about maintaining full control over their reproductive decisions. Finally, and most importantly, the couple may grapple with a difficult choice of whether to continue the pregnancy once they find out that their future child will likely be born with a genetic condition.
Assessment of the Couple
As a couple’s primary care provider, I will begin the assessment by evaluating their medical and family history. I will then move to risk identification and discussion of concerns. The first step in estimating the couple’s need for genetic testing is gathering a comprehensive medical history from both parents. This process will involve asking the spouses about their past surgeries, medications, and conditions.
Most importantly, medical history should involve any known genetic conditions within both spouses’ families. The latter overlaps with family history, as it is necessary to identify any known genetic factors and disease patterns that may suggest a hereditary component. While the core aspects of the patients’ family history have been provided by their nurse-midwife, the primary care provider still needs to interview the couple in more detail about these issues.
The next important phase of the assessment is identifying the risks to the baby’s health. For instance, such factors as the advanced age of the parents and genetic disorders in the family history increase the likelihood of having a child with a genetic condition. In this regard, it will be necessary to discuss the couple’s apprehensions and goals regarding genetic testing and to provide information that will support their decision-making process.
Suggested Interventions to Support the Couple
To promote the couple’s understanding of the necessity and potential benefits of genetic screening, it is crucial to be sympathetic and understanding but remain professional and goal-oriented. Several interventions can be offered to support the couple who have mixed feelings about genetic testing, including emotional support, clarification of values and concerns, facilitation of communication, respect for autonomy, and genetic counseling referral. The primary suggestion is to validate the couple’s emotions and offer empathetic support.
As a provider, I will acknowledge their mixed feelings and reassure them that there is nothing wrong with having second thoughts related to such testing. Another approach is to clarify their values and difficulties, in which case my role is to encourage them to express their current beliefs about genetic testing. This knowledge will help me to choose the best information and line of support to guide their decision.
Facilitation of communication can be manifested through generating an open and honest discussion with the couple, during which I will enable them to express their thoughts and fears in a supportive environment. As for respect for autonomy, I will achieve it by avoiding judgment and refraining from imposing my personal beliefs. Finally, if all other interventions fail, I will refer the couple to a genetic counselor for further assessment. These professionals are trained to guide couples through the decision-making process regarding genetic testing, so such a referral may be the most viable option for future parents.
Conclusion
Healthcare providers fully realize the importance of timely testing and diagnostics. However, they cannot impose their professional or personal views on patients. When a couple is hesitating about genetic screening, it is vital to offer information and guidance while respecting their autonomy and privacy. Explaining the advantages of genetic testing and providing additional guidance and support can help couples decide in favor of testing.
References
Erlich, H. A., López-Peña, C., Carlberg, C. T., Shih, S., Bali, G., Yamaguchi, K. D., Salamon, H., Das, R., Lal, A., & Calloway, C. D. (2022). Noninvasive prenatal test for b-thalassemia and sickle cell disease using probe capture enrichment and next-generation sequencing of DNA in maternal plasma. The Journal of Applied Laboratory Medicine, 7(2), 515-531.
Farrell, P. M., Rock, M. J., & Baker, M. W. (2020). The impact of the CFTR gene discovery on cystic fibrosis diagnosis, counseling, and preventive therapy. Genes, 11(4), 401.
Kessels, S. J. M., Carter, D., Ellery, B., Newton, S., & Merlin, T. L. (2020). Prenatal genetic testing for cystic fibrosis: A systematic review of clinical effectiveness and an ethics review. Genetics in Medicine, 22(2), 258-267.